Osteoporosis during the hormonal therapy of prostate cancer and markers of bone tissue remodeling
Osteoporosis could be present in the different conditions: oncologic, endocrinologic and rheumatologic diseases, diseases of the gastrointestinal system, kidneys, lungs and also as the complication of the intake of somemedications (corticosteroids, gonadotropin-releasing-hormone analogues (GnRH-A), etc.). According to the literature data, osteoporosis develops in 40-50% of patients with prostate cancer after 2 years on GnRG-A.
- Read more about Osteoporosis during the hormonal therapy of prostate cancer and markers of bone tissue remodeling
- Log in or register to post comments
- 15663 views